8158 — China Regenerative Medicine International Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Market Cap
HK$85.19m
Enterprise Value
HK$132.05m
Revenue
HK$69.49m

Annual balance sheet for China Regenerative Medicine International, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	HKAS	HKAS	HKAS	HKAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	309	4.77	9.93	1.85	3.33
Net Total Accounts Receivable
Net Total Receivables	7.31	117	197	238	1.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	344	144	258	249	169
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.52	1.3	0.753	26.8	17.3
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	554	152	259	276	186
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	301	201	147	158	148
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Liabilities	461	94.4	147	172	174
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	92.8	58.1	112	104	11.8
Total Liabilities & Shareholders' Equity	554	152	259	276	186
Total Common Shares Outstanding